Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | PI | Common Stock | Sale | -$110K | -991 | -0.34% | $111.34 | 288K | Nov 1, 2022 | Direct | F1, F2 |
transaction | PI | Common Stock | Sale | -$12.3K | -109 | -0.04% | $112.58 | 288K | Nov 1, 2022 | Direct | F1, F3 |
transaction | PI | Common Stock | Sale | -$222K | -1.96K | -0.68% | $113.28 | 286K | Nov 1, 2022 | Direct | F1, F4 |
transaction | PI | Common Stock | Sale | -$176K | -1.54K | -0.54% | $114.34 | 285K | Nov 1, 2022 | Direct | F1, F5 |
transaction | PI | Common Stock | Sale | -$46.3K | -401 | -0.14% | $115.50 | 284K | Nov 1, 2022 | Direct | F1, F6 |
transaction | PI | Common Stock | Other | $0 | -17.5K | -2.97% | $0.00 | 572K | Nov 1, 2022 | by DFT L.L.C | F7 |
transaction | PI | Common Stock | Other | $0 | +8.33K | +2.93% | $0.00 | 293K | Nov 1, 2022 | Direct | F7, F8 |
transaction | PI | Common Stock | Gift | $0 | -10K | -3.42% | $0.00 | 283K | Nov 2, 2022 | Direct |
Id | Content |
---|---|
F1 | The sales reported by Dr. Diorio were effected pursuant to a Rule 10b5-1 trading plan adopted on May 27, 2022. |
F2 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $110.83 to $111.76, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F3 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $111.90 to $112.71, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F4 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $112.90 to $113.86, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F5 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $113.93 to $114.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F6 | The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $114.97 to $115.95, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. |
F7 | Distribution of Common Stock held by DFT L.L.C. to its members for no consideration. |
F8 | Change from indirect to direct ownership of shares previously reported as beneficially owned by the reporting person. |